Literature DB >> 30185689

Clonal Hematopoiesis and Its Impact on Cardiovascular Disease.

Soichi Sano1, Ying Wang1, Kenneth Walsh1.   

Abstract

A number of recent epidemiological studies have associated the clonal expansion of hematopoietic cells, a process referred to as clonal hematopoiesis, with increased mortality. Clonal hematopoiesis increases the risk of hematological cancer, but this overall risk cannot account for the increase in mortality in the general population. Surprisingly, these mutations have also been associated with higher rates of cardiovascular disease, suggesting a previously unrecognized link between somatic mutations in hematopoietic cells and chronic disease. Here, we review recent epidemiological and experimental studies on clonal hematopoiesis that relate to cardiovascular disease.

Entities:  

Keywords:  Atherosclerosis; Clonal hematopoiesis; Heart failure; Hematopoietic stem cells

Mesh:

Year:  2018        PMID: 30185689      PMCID: PMC6310086          DOI: 10.1253/circj.CJ-18-0871

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  101 in total

1.  Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.

Authors:  Paul M Ridker; Jean G MacFadyen; Brendan M Everett; Peter Libby; Tom Thuren; Robert J Glynn
Journal:  Lancet       Date:  2017-11-13       Impact factor: 79.321

2.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.

Authors:  Giulio Genovese; Anna K Kähler; Robert E Handsaker; Johan Lindberg; Samuel A Rose; Samuel F Bakhoum; Kimberly Chambert; Eran Mick; Benjamin M Neale; Menachem Fromer; Shaun M Purcell; Oscar Svantesson; Mikael Landén; Martin Höglund; Sören Lehmann; Stacey B Gabriel; Jennifer L Moran; Eric S Lander; Patrick F Sullivan; Pamela Sklar; Henrik Grönberg; Christina M Hultman; Steven A McCarroll
Journal:  N Engl J Med       Date:  2014-11-26       Impact factor: 91.245

3.  Quantification of biological aging in young adults.

Authors:  Daniel W Belsky; Avshalom Caspi; Renate Houts; Harvey J Cohen; David L Corcoran; Andrea Danese; HonaLee Harrington; Salomon Israel; Morgan E Levine; Jonathan D Schaefer; Karen Sugden; Ben Williams; Anatoli I Yashin; Richie Poulton; Terrie E Moffitt
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

4.  Identification of DNA methyltransferase 3a as a T cell receptor-induced regulator of Th1 and Th2 differentiation.

Authors:  Christopher J Gamper; Agoston T Agoston; William G Nelson; Jonathan D Powell
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

5.  Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms.

Authors:  David A Hinds; Kimberly E Barnholt; Ruben A Mesa; Amy K Kiefer; Chuong B Do; Nicholas Eriksson; Joanna L Mountain; Uta Francke; Joyce Y Tung; Huong Marie Nguyen; Haiyu Zhang; Linda Gojenola; James L Zehnder; Jason Gotlib
Journal:  Blood       Date:  2016-06-30       Impact factor: 22.113

6.  Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice.

Authors:  Rajinikanth Gogiraju; Xingbo Xu; Magdalena L Bochenek; Julia H Steinbrecher; Stephan E Lehnart; Philip Wenzel; Michael Kessel; Elisabeth M Zeisberg; Matthias Dobbelstein; Katrin Schäfer
Journal:  J Am Heart Assoc       Date:  2015-02-24       Impact factor: 5.501

7.  The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model.

Authors:  Yueh-Chwen Hsu; Yu-Chiao Chiu; Chien-Chin Lin; Yuan-Yeh Kuo; Hsin-An Hou; Yi-Shiuan Tzeng; Chein-Jun Kao; Po-Han Chuang; Mei-Hsuan Tseng; Tzu-Hung Hsiao; Wen-Chien Chou; Hwei-Fang Tien
Journal:  J Hematol Oncol       Date:  2017-07-11       Impact factor: 17.388

8.  Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer.

Authors:  Elise Ruark; Katie Snape; Peter Humburg; Chey Loveday; Ilirjana Bajrami; Rachel Brough; Daniel Nava Rodrigues; Anthony Renwick; Sheila Seal; Emma Ramsay; Silvana Del Vecchio Duarte; Manuel A Rivas; Margaret Warren-Perry; Anna Zachariou; Adriana Campion-Flora; Sandra Hanks; Anne Murray; Naser Ansari Pour; Jenny Douglas; Lorna Gregory; Andrew Rimmer; Neil M Walker; Tsun-Po Yang; Julian W Adlard; Julian Barwell; Jonathan Berg; Angela F Brady; Carole Brewer; Glen Brice; Cyril Chapman; Jackie Cook; Rosemarie Davidson; Alan Donaldson; Fiona Douglas; Diana Eccles; D Gareth Evans; Lynn Greenhalgh; Alex Henderson; Louise Izatt; Ajith Kumar; Fiona Lalloo; Zosia Miedzybrodzka; Patrick J Morrison; Joan Paterson; Mary Porteous; Mark T Rogers; Susan Shanley; Lisa Walker; Martin Gore; Richard Houlston; Matthew A Brown; Mark J Caufield; Panagiotis Deloukas; Mark I McCarthy; John A Todd; Clare Turnbull; Jorge S Reis-Filho; Alan Ashworth; Antonis C Antoniou; Christopher J Lord; Peter Donnelly; Nazneen Rahman
Journal:  Nature       Date:  2012-12-16       Impact factor: 49.962

9.  Detectable clonal mosaicism from birth to old age and its relationship to cancer.

Authors:  Cathy C Laurie; Cecelia A Laurie; Kenneth Rice; Kimberly F Doheny; Leila R Zelnick; Caitlin P McHugh; Hua Ling; Kurt N Hetrick; Elizabeth W Pugh; Chris Amos; Qingyi Wei; Li-e Wang; Jeffrey E Lee; Kathleen C Barnes; Nadia N Hansel; Rasika Mathias; Denise Daley; Terri H Beaty; Alan F Scott; Ingo Ruczinski; Rob B Scharpf; Laura J Bierut; Sarah M Hartz; Maria Teresa Landi; Neal D Freedman; Lynn R Goldin; David Ginsburg; Jun Li; Karl C Desch; Sara S Strom; William J Blot; Lisa B Signorello; Sue A Ingles; Stephen J Chanock; Sonja I Berndt; Loic Le Marchand; Brian E Henderson; Kristine R Monroe; John A Heit; Mariza de Andrade; Sebastian M Armasu; Cynthia Regnier; William L Lowe; M Geoffrey Hayes; Mary L Marazita; Eleanor Feingold; Jeffrey C Murray; Mads Melbye; Bjarke Feenstra; Jae H Kang; Janey L Wiggs; Gail P Jarvik; Andrew N McDavid; Venkatraman E Seshan; Daniel B Mirel; Andrew Crenshaw; Nataliya Sharopova; Anastasia Wise; Jess Shen; David R Crosslin; David M Levine; Xiuwen Zheng; Jenna I Udren; Siiri Bennett; Sarah C Nelson; Stephanie M Gogarten; Matthew P Conomos; Patrick Heagerty; Teri Manolio; Louis R Pasquale; Christopher A Haiman; Neil Caporaso; Bruce S Weir
Journal:  Nat Genet       Date:  2012-05-06       Impact factor: 38.330

10.  Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation.

Authors:  Reina Nagase; Daichi Inoue; Alessandro Pastore; Takeshi Fujino; Hsin-An Hou; Norimasa Yamasaki; Susumu Goyama; Makoto Saika; Akinori Kanai; Yasuyuki Sera; Sayuri Horikawa; Yasunori Ota; Shuhei Asada; Yasutaka Hayashi; Kimihito Cojin Kawabata; Reina Takeda; Hwei-Fang Tien; Hiroaki Honda; Omar Abdel-Wahab; Toshio Kitamura
Journal:  J Exp Med       Date:  2018-04-11       Impact factor: 14.307

View more
  19 in total

1.  Highlighting Residual Atherosclerotic Cardiovascular Disease Risk.

Authors:  Yunosuke Matsuura; Jenny E Kanter; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

Review 2.  Cardiovascular Disease, Aging, and Clonal Hematopoiesis.

Authors:  Megan A Evans; Soichi Sano; Kenneth Walsh
Journal:  Annu Rev Pathol       Date:  2019-11-05       Impact factor: 23.472

Review 3.  Clonal hematopoiesis: Mutation-specific adaptation to environmental change.

Authors:  Marcus A Florez; Brandon T Tran; Trisha K Wathan; James DeGregori; Eric M Pietras; Katherine Y King
Journal:  Cell Stem Cell       Date:  2022-06-02       Impact factor: 25.269

Review 4.  Immune and Inflammatory Networks in Myocardial Infarction: Current Research and Its Potential Implications for the Clinic.

Authors:  Atsushi Anzai; Seien Ko; Keiichi Fukuda
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

Review 5.  Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review.

Authors:  Orly Leiva; Gabriela Hobbs; Katya Ravid; Peter Libby
Journal:  JACC CardioOncol       Date:  2022-06-21

6.  Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction.

Authors:  Ying Wang; Soichi Sano; Yoshimitsu Yura; Zhonghe Ke; Miho Sano; Kosei Oshima; Hayato Ogawa; Keita Horitani; Kyung-Duk Min; Emiri Miura-Yura; Anupreet Kour; Megan A Evans; Maria A Zuriaga; Karen K Hirschi; Jose J Fuster; Eric M Pietras; Kenneth Walsh
Journal:  JCI Insight       Date:  2020-03-26

Review 7.  Evidence of Clonal Hematopoiesis and Risk of Heart Failure.

Authors:  Peter Bazeley; Rommel Morales; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2020-10

Review 8.  Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies.

Authors:  Nazha Hamdani; Sarah Costantino; Andreas Mügge; Djamel Lebeche; Carsten Tschöpe; Thomas Thum; Francesco Paneni
Journal:  Eur Heart J       Date:  2021-05-21       Impact factor: 29.983

9.  Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models.

Authors:  Soichi Sano; Ying Wang; Megan A Evans; Yoshimitsu Yura; Miho Sano; Hayato Ogawa; Keita Horitani; Heather Doviak; Kenneth Walsh
Journal:  J Vis Exp       Date:  2019-10-03       Impact factor: 1.355

Review 10.  Clonal Hematopoiesis and Premalignant Diseases.

Authors:  Justin Kaner; Pinkal Desai; Nuria Mencia-Trinchant; Monica L Guzman; Gail J Roboz; Duane C Hassane
Journal:  Cold Spring Harb Perspect Med       Date:  2020-04-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.